Articles with public access mandates - Zubida M. Al-MajdoubLearn more
Available somewhere: 5
Proteomic quantification of human blood–brain barrier SLC and ABC transporters in healthy individuals and dementia patients
ZM Al-Majdoub, H Al Feteisi, B Achour, S Warwood, S Neuhoff, ...
Molecular Pharmaceutics 16 (3), 1220-1233, 2019
Mandates: Alzheimers's UK
Quantification of proteins involved in drug metabolism and disposition in the human liver using label-free global proteomics
N Couto, ZM Al-Majdoub, B Achour, PC Wright, A Rostami-Hodjegan, ...
Molecular Pharmaceutics 16 (2), 632-647, 2019
Mandates: UK Biotechnology and Biological Sciences Research Council, UK Engineering …
Mass spectrometry‐based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin
ZM Al‐Majdoub, B Achour, N Couto, M Howard, Y Elmorsi, D Scotcher, ...
FEBS letters 594 (23), 4134-4150, 2020
Mandates: US National Institutes of Health, Alzheimers's UK, UK Biotechnology and …
Label-free quantitative proteomics and substrate-based mass spectrometry imaging of xenobiotic metabolizing enzymes in ex vivo human skin and a human living skin equivalent model
N Couto, JRA Newton, C Russo, E Karunakaran, B Achour, ...
Drug Metabolism and Disposition 49 (1), 39-52, 2021
Mandates: US National Institutes of Health, UK Biotechnology and Biological Sciences …
Label-free but still constrained: assessment of global proteomic strategies for the quantification of hepatic enzymes and transporters
J Barber, ZM Al-Majdoub, N Couto, AM Vasilogianni, A Tillmann, ...
Drug Metabolism and Disposition 50 (6), 762-769, 2022
Mandates: Cancer Research UK, European Commission
Publication and funding information is determined automatically by a computer program